Another lncRNA that seems to exert a critical role in NAFLD-related HCC is MALAT1, whose expression was found to be elevated in liver tissue of NAFLD patients and HepG2 cells treated with 1 mM of FFA as an NAFLD in vitro model [99]. Here, MALAT1 is linked to metabolic dysfunction-associated steatotic liver disease.